Clinical trials of the Russian cancer vaccine could begin in mid-2025. This was reported by TASSIt is named after the director of the National Center for Research in Epidemiology and Microbiology (NICEM), NF Gamaleya Alexander Ginzburg.
Gunzburg in June It has been said The Russian cancer vaccine is based on mRNA (as are the Pfizer and Moderna COVID-19 vaccines), socialbites.ca reported. The drug will help train the human immune system to distinguish a cancer cell from a healthy one. The vaccine will be administered to people who already have cancer. The drugs will be created individually for each patient.
According to Gunzburg, experimental animals that received cancer vaccines survived. Unvaccinated individuals did not survive more than 22 days.
The same month, Russian Health Minister Mikhail Murashko It has been saidIt was stated that the first results of pre-clinical studies on the cancer vaccine could be presented at the end of 2024.
Previously in England started Large-scale cancer vaccine trials.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.